{{Rsnum
|rsid=1800977
|Gene=ABCA1
|Chromosome=9
|position=104928169
|Orientation=minus
|GMAF=0.3416
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|effect1=
|effect2=
|effect3=
|Gene_s=ABCA1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.9 | 40.7 | 12.4
| HCB | 46.7 | 44.5 | 8.8
| JPT | 47.3 | 43.8 | 8.9
| YRI | 61.0 | 33.6 | 5.5
| ASW | 54.4 | 35.1 | 10.5
| CHB | 46.7 | 44.5 | 8.8
| CHD | 45.9 | 44.0 | 10.1
| GIH | 34.7 | 42.6 | 22.8
| LWK | 58.7 | 39.4 | 1.8
| MEX | 27.6 | 51.7 | 20.7
| MKK | 51.9 | 42.9 | 5.1
| TSI | 41.2 | 42.2 | 16.7
| HapMapRevision=28
}}The -14C->T polymorphism [[rs1800977]] of the [[ABCA1]] gene was significantly associated with atherothrombotic cerebral infarction in a study of 3,400+ Japanese adults.{{PMID|18566305}}

{{PMID Auto
|PMID=19446537
|Title=Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=21840005
|Title=ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}